Table 2.

Findings on the second renal biopsy.

PatientReason for BiopsySerum Creatinine at Time of Biopsy, (mg/dl)BVAS/WG at Time of BiopsyESR at Time of BiopsyANCA at Time of BiopsyRenal Biopsy FindingsFollowup from First Biopsy, (mo)Serum Creatinine (mg/dl) at Last FollowupProteinuria (mg) at Last Followup
1Persistent hematuria1.1117NegativeNormal glomeruli, moderate arteriosclerosis761.4200
2Persistent hematuria1.4143Persistent positiveModerate arteriosclerosis781.5593
3Persistent hematuria1.9119Persistent positiveSecondary FSGS, hypertensive renal diseaseNAESRDNA
4Persistent hematuria2.0136Persistent positiveChronic global and segmental glomerulosclerosis483.12400
5Persistent hematuria2.5136Persistent positiveChronic crescentic GN, secondary FSGS282.6NA
6Persistent hematuria1.21NANegativeChronic crescentic GN711.2NA
7New onset hematuria1.0129NegativeChronic crescentic GN561.81200
8New onset hematuria1.3112NegativeCrescentic IgA1801.3700
9New onset hematuria1.5423NegativeCrescentic IgA1941.1115
  • ESR: erythrocyte sedimentation rate; ANCA: antineutrophil cytoplasmic antibody; FSGS: focal segmental glomerulosclerosis; GN: glomerulonephritis; BVAS/WG: Birmingham Vasculitis Activity Score/Wegener’s granulomatosis; NA: not applicable; ESRD: endstage renal disease.